Showing results (201-210 of 207) with videos related to
Sort By:
Pageof 21
You have reached the last page of results.This site can display upto 207 results.
JCI Insight|December 3, 2020
TP-0903 is active in models of drug-resistant acute myeloid leukemiaJae Yoon Jeon, Daelynn R Buelow, Dominique A Garrison, et al.Diabetes|December 29, 2005
Muraglitazar, a novel dual (alpha/gamma) peroxisome proliferator-activated receptor activator, improves diabetes and other metabolic abnormalities and preserves beta-cell function in db/db miceThomas Harrity, Dennis Farrelly, Aaron Tieman, et al.Journal of Medicinal Chemistry|March 18, 2005
Design and synthesis of N-[(4-methoxyphenoxy)carbonyl]-N-[[4-[2-(5- methyl-2-phenyl-4-oxazolyl)ethoxy]phenyl]methyl]glycine [Muraglitazar/BMS-298585], a novel peroxisome proliferator-activated receptor alpha/gamma dual agonist with efficacious glucose and lipid-lowering activitiesPratik V Devasthale, Sean Chen, Yoon Jeon, et al.Bioorganic & Medicinal Chemistry Letters|August 26, 2019
Structure based design of macrocyclic factor XIa inhibitors: Discovery of cyclic P1 linker moieties with improved oral bioavailabilityCharles G Clark, Karen A Rossi, James R Corte, et al.Journal of Medicinal Chemistry|May 28, 2020
Discovery of a High Affinity, Orally Bioavailable Macrocyclic FXIa Inhibitor with Antithrombotic Activity in Preclinical SpeciesWu Yang, Yufeng Wang, Amy Lai, et al.Frontiers in Immunology|December 19, 2022
Corrigendum: Mouse models of lung-specific SARS-CoV-2 infection with moderate pathological traitsSung-Hee Kim, Jiseon Kim, Ji Yun Jang, et al.Frontiers in Immunology|December 2, 2022
Mouse models of lung-specific SARS-CoV-2 infection with moderate pathological traitsSung-Hee Kim, Jiseon Kim, Ji Yun Jang, et al.Pageof 21